BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ciprofibrate
,
rs6983267
,
LEP
,
calcium channel activity
,
Arthritis
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ach
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia.
Evaluation of Volumetric Bone Mineral Density, Bone Microarchitecture, and Bone Strength in Patients…
Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year r…
Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: A Review.
Achondroplasia-First Report from India of a Rare FGFR3 Gene Variant.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volu…
A Phase I DDI Study Between ACH-0144471 and Midazolam, Fexofenadine and Mycophenolate Mofetil
Extension Study of Infigratinib in Children With Achondroplasia (ACH)
A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule…
A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ